Pancreas allograft rejection: Analysis of concurrent renal allograft biopsies and posttherapy follow-up biopsies

Megan Troxell, David Bradley Koslin, Douglas Norman, Stephen Rayhill, Anuja Mittalhenkle

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Background: Pancreas and kidney allograft function is routinely monitored with serum studies (amylase, lipase, and creatinine). Increased levels commonly prompt tissue biopsy, to diagnose cause of graft dysfunction. Historically, pancreas allografts were infrequently biopsied, although serum enzymes and renal rejection may be poor surrogates for pancreas status. Methods: Pancreas allograft biopsies at our center were reviewed and reclassified according to University of Maryland (UMD) and Banff criteria; C4d immunostaining was performed. Findings were correlated with clinical data and renal allograft biopsies. Results: Fifty-six pancreas allograft biopsies from 27 patients were evaluated. UMD and Banff grading were similar, although two UMD "indeterminate" biopsies were Banff grade 1 rejection. There were 21 concurrent pancreas and renal biopsies, all from simultaneous pancreas-kidney allograft recipients. Thirteen pairs were concordant for rejection; eight pairs were discordant for rejection (38%); six pairs showed pancreas rejection without kidney rejection, and two pairs showed the converse.Fourteen patients had a total of 21 follow-up pancreas allograft biopsies. Seven biopsies showed a lower grade of rejection on follow-up biopsy, 4 biopsies showed more severe rejection, and 10 had unchanged grade. In only 9 of these 21 (43%) cases, did the interval serum amylase or lipase trend parallel the subsequent biopsy diagnosis. ConclusionS: With a high biopsy discordance rate, our data suggest that renal allograft rejection is a poor surrogate for pancreas allograft status. Likewise, serum amylase and lipase levels do not predict response to rejection therapy. Surveillance or posttherapy pancreas allograft biopsies may be a useful means to monitor pancreas allograft status.

Original languageEnglish (US)
Pages (from-to)75-84
Number of pages10
JournalTransplantation
Volume90
Issue number1
DOIs
StatePublished - Jul 15 2010

Fingerprint

Allografts
Pancreas
Kidney
Biopsy
Amylases
Lipase
Serum
Creatinine
Transplants

Keywords

  • Amylase
  • Lipase.
  • Pancreas allograft
  • Rejection
  • Renal allograft

ASJC Scopus subject areas

  • Transplantation

Cite this

Pancreas allograft rejection : Analysis of concurrent renal allograft biopsies and posttherapy follow-up biopsies. / Troxell, Megan; Koslin, David Bradley; Norman, Douglas; Rayhill, Stephen; Mittalhenkle, Anuja.

In: Transplantation, Vol. 90, No. 1, 15.07.2010, p. 75-84.

Research output: Contribution to journalArticle

Troxell, Megan ; Koslin, David Bradley ; Norman, Douglas ; Rayhill, Stephen ; Mittalhenkle, Anuja. / Pancreas allograft rejection : Analysis of concurrent renal allograft biopsies and posttherapy follow-up biopsies. In: Transplantation. 2010 ; Vol. 90, No. 1. pp. 75-84.
@article{407d26c31e714226b632e55a64ae28ce,
title = "Pancreas allograft rejection: Analysis of concurrent renal allograft biopsies and posttherapy follow-up biopsies",
abstract = "Background: Pancreas and kidney allograft function is routinely monitored with serum studies (amylase, lipase, and creatinine). Increased levels commonly prompt tissue biopsy, to diagnose cause of graft dysfunction. Historically, pancreas allografts were infrequently biopsied, although serum enzymes and renal rejection may be poor surrogates for pancreas status. Methods: Pancreas allograft biopsies at our center were reviewed and reclassified according to University of Maryland (UMD) and Banff criteria; C4d immunostaining was performed. Findings were correlated with clinical data and renal allograft biopsies. Results: Fifty-six pancreas allograft biopsies from 27 patients were evaluated. UMD and Banff grading were similar, although two UMD {"}indeterminate{"} biopsies were Banff grade 1 rejection. There were 21 concurrent pancreas and renal biopsies, all from simultaneous pancreas-kidney allograft recipients. Thirteen pairs were concordant for rejection; eight pairs were discordant for rejection (38{\%}); six pairs showed pancreas rejection without kidney rejection, and two pairs showed the converse.Fourteen patients had a total of 21 follow-up pancreas allograft biopsies. Seven biopsies showed a lower grade of rejection on follow-up biopsy, 4 biopsies showed more severe rejection, and 10 had unchanged grade. In only 9 of these 21 (43{\%}) cases, did the interval serum amylase or lipase trend parallel the subsequent biopsy diagnosis. ConclusionS: With a high biopsy discordance rate, our data suggest that renal allograft rejection is a poor surrogate for pancreas allograft status. Likewise, serum amylase and lipase levels do not predict response to rejection therapy. Surveillance or posttherapy pancreas allograft biopsies may be a useful means to monitor pancreas allograft status.",
keywords = "Amylase, Lipase., Pancreas allograft, Rejection, Renal allograft",
author = "Megan Troxell and Koslin, {David Bradley} and Douglas Norman and Stephen Rayhill and Anuja Mittalhenkle",
year = "2010",
month = "7",
day = "15",
doi = "10.1097/TP.0b013e3181dda17e",
language = "English (US)",
volume = "90",
pages = "75--84",
journal = "Transplantation",
issn = "0041-1337",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Pancreas allograft rejection

T2 - Analysis of concurrent renal allograft biopsies and posttherapy follow-up biopsies

AU - Troxell, Megan

AU - Koslin, David Bradley

AU - Norman, Douglas

AU - Rayhill, Stephen

AU - Mittalhenkle, Anuja

PY - 2010/7/15

Y1 - 2010/7/15

N2 - Background: Pancreas and kidney allograft function is routinely monitored with serum studies (amylase, lipase, and creatinine). Increased levels commonly prompt tissue biopsy, to diagnose cause of graft dysfunction. Historically, pancreas allografts were infrequently biopsied, although serum enzymes and renal rejection may be poor surrogates for pancreas status. Methods: Pancreas allograft biopsies at our center were reviewed and reclassified according to University of Maryland (UMD) and Banff criteria; C4d immunostaining was performed. Findings were correlated with clinical data and renal allograft biopsies. Results: Fifty-six pancreas allograft biopsies from 27 patients were evaluated. UMD and Banff grading were similar, although two UMD "indeterminate" biopsies were Banff grade 1 rejection. There were 21 concurrent pancreas and renal biopsies, all from simultaneous pancreas-kidney allograft recipients. Thirteen pairs were concordant for rejection; eight pairs were discordant for rejection (38%); six pairs showed pancreas rejection without kidney rejection, and two pairs showed the converse.Fourteen patients had a total of 21 follow-up pancreas allograft biopsies. Seven biopsies showed a lower grade of rejection on follow-up biopsy, 4 biopsies showed more severe rejection, and 10 had unchanged grade. In only 9 of these 21 (43%) cases, did the interval serum amylase or lipase trend parallel the subsequent biopsy diagnosis. ConclusionS: With a high biopsy discordance rate, our data suggest that renal allograft rejection is a poor surrogate for pancreas allograft status. Likewise, serum amylase and lipase levels do not predict response to rejection therapy. Surveillance or posttherapy pancreas allograft biopsies may be a useful means to monitor pancreas allograft status.

AB - Background: Pancreas and kidney allograft function is routinely monitored with serum studies (amylase, lipase, and creatinine). Increased levels commonly prompt tissue biopsy, to diagnose cause of graft dysfunction. Historically, pancreas allografts were infrequently biopsied, although serum enzymes and renal rejection may be poor surrogates for pancreas status. Methods: Pancreas allograft biopsies at our center were reviewed and reclassified according to University of Maryland (UMD) and Banff criteria; C4d immunostaining was performed. Findings were correlated with clinical data and renal allograft biopsies. Results: Fifty-six pancreas allograft biopsies from 27 patients were evaluated. UMD and Banff grading were similar, although two UMD "indeterminate" biopsies were Banff grade 1 rejection. There were 21 concurrent pancreas and renal biopsies, all from simultaneous pancreas-kidney allograft recipients. Thirteen pairs were concordant for rejection; eight pairs were discordant for rejection (38%); six pairs showed pancreas rejection without kidney rejection, and two pairs showed the converse.Fourteen patients had a total of 21 follow-up pancreas allograft biopsies. Seven biopsies showed a lower grade of rejection on follow-up biopsy, 4 biopsies showed more severe rejection, and 10 had unchanged grade. In only 9 of these 21 (43%) cases, did the interval serum amylase or lipase trend parallel the subsequent biopsy diagnosis. ConclusionS: With a high biopsy discordance rate, our data suggest that renal allograft rejection is a poor surrogate for pancreas allograft status. Likewise, serum amylase and lipase levels do not predict response to rejection therapy. Surveillance or posttherapy pancreas allograft biopsies may be a useful means to monitor pancreas allograft status.

KW - Amylase

KW - Lipase.

KW - Pancreas allograft

KW - Rejection

KW - Renal allograft

UR - http://www.scopus.com/inward/record.url?scp=77954622197&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954622197&partnerID=8YFLogxK

U2 - 10.1097/TP.0b013e3181dda17e

DO - 10.1097/TP.0b013e3181dda17e

M3 - Article

C2 - 20548259

AN - SCOPUS:77954622197

VL - 90

SP - 75

EP - 84

JO - Transplantation

JF - Transplantation

SN - 0041-1337

IS - 1

ER -